Leptomeningeal carcinomatosis in patients with breast cancer

MA Franzoi, GN Hortobagyi - Critical reviews in oncology/hematology, 2019 - Elsevier
Leptomeningeal carcinomatosis (LC) is defined as infiltration of the leptomeninges by
metastatic carcinoma, a relatively uncommon but devastating complication of many …

[HTML][HTML] Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival

A Niwińska, H Rudnicka, M Murawska - Medical oncology, 2013 - Springer
The aim of the study was to define biological subtypes of breast cancer that have the
propensity to metastasize to the leptomeninges and to assess factors influencing survival …

Leptomeningeal disease and breast cancer: the importance of tumor subtype

S Abouharb, J Ensor, ME Loghin, R Katz… - Breast cancer research …, 2014 - Springer
Breast cancer (BC) is one of the most common tumors to involve the leptomeninges. We
aimed to characterize clinical features and outcomes of patients with LMD based on BC …

Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled …

F Zagouri, TN Sergentanis, R Bartsch… - Breast cancer research …, 2013 - Springer
Leptomeningeal carcinomatosis (MC) represents an uncommon, but devasting
manifestation of metastatic breast cancer. This is the first systematic review/pooled analysis …

Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report

HJ Stemmler, K Mengele, M Schmitt, N Harbeck… - Anti-cancer …, 2008 - journals.lww.com
Leptomeningeal carcinomatosis represents a rare manifestation of metastatic breast cancer
(MBC). We herewith report on a patient suffering from HER2 overexpressing MBC who …

[HTML][HTML] Leptomeningeal metastasis in breast cancer–a systematic review

BJ Scott, NA Oberheim-Bush, S Kesari - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background There is limited data on the impact of specific patient characteristics, tumor
subtypes or treatment interventions on survival in breast cancer LM. Methods A systematic …

[PDF][PDF] The diagnostic and therapeutic management of leptomeningeal carcinomatosis

N Pavlidis - Ann Oncol, 2004 - academia.edu
The infiltration of the leptomeninges by malignant cells is not an uncommon complication of
cancer and is called carcinomatous meningitis or leptomeningeal carcinomatosis (LC) …

[HTML][HTML] A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

PF Wu, CH Lin, CH Kuo, WW Chen, DC Yeh, HW Liao… - BMC cancer, 2015 - Springer
Background Elevated vascular endothelial growth factor (VEGF) was associated with poor
prognosis in leptomeningeal carcinomatosis and anti-angiogenic therapy was found to …

Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations

S Lee, HK Ahn, YH Park, DH Nam, JI Lee… - Breast cancer research …, 2011 - Springer
Leptomeningeal metastasis (LM) usually occurs late during the course of breast cancer. The
aim of this study was to characterize the clinical features and outcomes of LM based on …

Leptomeningeal carcinomatosis

SA Grossman, MJ Krabak - Cancer treatment reviews, 1999 - cancertreatmentreviews.com
Leptomeningeal carcinomatosis occurs in approximately 5% of patients with cancer. This
disorder is being diagnosed with increasing frequency as patients live longer and as neuro …